Further humoral immunity evasion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants

Affiliations

• ¹ Biomedical Pioneering Innovation Center, Peking University, Beijing, China; College of Chemistry and Molecular Engineering, Peking University, Beijing, China.
• ² Changping Laboratory, Beijing, China.
• ³ Biomedical Pioneering Innovation Center, Peking University, Beijing, China; School of Life Sciences, Peking University, Beijing, China.
• ⁴ Beijing Ditan Hospital, Capital Medical University, Beijing, China.
• ⁵ Biomedical Pioneering Innovation Center, Peking University, Beijing, China.
• ⁶ Changping Laboratory, Beijing, China; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control, Beijing, China.
• ⁷ Biomedical Pioneering Innovation Center, Peking University, Beijing, China; Changping Laboratory, Beijing, China. Electronic address: sunneyxie@biopic.pku.edu.cn.
• ⁸ Biomedical Pioneering Innovation Center, Peking University, Beijing, China; Changping Laboratory, Beijing, China. Electronic address: yunlongcao@pku.edu.cn.